Michael Barbella, Managing Editor11.07.17
Call it the Year of Resolution.
The medtech industry showed steely resolve this year in the wake of political chaos and meteorological mayhem, shortening supply chains and streamlining operations to weather the impacts of a tyrannical hurricane trifecta, and maintaining the fight for full repeal of the 2.3 percent medical device tax.
That battle proved challenging, as the controversial levy became lost among a litany of woes endangering President Donald Trump’s legislative agenda, among them: multiple investigations into Russian interference in the 2016 election; former FBI Director James Comey’s controversial firing; staff infighting; the ban on transgender military personnel; high-profile resignations; the president’s word war with North Korean leader Kim Jong-un; and vacillating tensions with Congress.
Despite all the turmoil, the industry never strayed from its goal, though it did eventually adjust its expectations. “There are opportunities—fewer and fewer though to get full repeal,” Clayton Hall, vice president of government affairs for the Medical Device Manufacturers Associa
The medtech industry showed steely resolve this year in the wake of political chaos and meteorological mayhem, shortening supply chains and streamlining operations to weather the impacts of a tyrannical hurricane trifecta, and maintaining the fight for full repeal of the 2.3 percent medical device tax.
That battle proved challenging, as the controversial levy became lost among a litany of woes endangering President Donald Trump’s legislative agenda, among them: multiple investigations into Russian interference in the 2016 election; former FBI Director James Comey’s controversial firing; staff infighting; the ban on transgender military personnel; high-profile resignations; the president’s word war with North Korean leader Kim Jong-un; and vacillating tensions with Congress.
Despite all the turmoil, the industry never strayed from its goal, though it did eventually adjust its expectations. “There are opportunities—fewer and fewer though to get full repeal,” Clayton Hall, vice president of government affairs for the Medical Device Manufacturers Associa
Continue reading this story and get 24/7 access to Medical Product Outsourcing for FREE
Our in-depth coverage includes comprehensive feature articles, industry news, trends, and other developments pertinent to the service provider-OEM relationship. MPO examines the increasingly complex and demanding requirements of managing outsourcing partnerships. From regulatory mandates and manufacturing best practices to market shifts and legal concerns, our website is filled with exclusive content to help device manufacturers and their vendors stay informed. Join Today!
FREE SUBSCRIPTION
